HomeHROW • NASDAQ
Follow
Harrow Inc
Previous close
$12.73
Day range
$12.70 - $13.48
Year range
$7.60 - $28.25
Market cap
467.85M USD
Avg Volume
537.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 36.36M | 78.83% |
Operating expense | 29.55M | 85.35% |
Net income | -9.15M | -967.11% |
Net profit margin | -25.16 | -584.78% |
Earnings per share | -0.20 | -405.81% |
EBITDA | -1.74M | -61.40% |
Effective tax rate | 5.53% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 84.52M | -17.12% |
Total assets | 312.16M | 98.35% |
Total liabilities | 241.75M | 85.77% |
Total equity | 70.41M | — |
Shares outstanding | 35.36M | — |
Price to book | 6.33 | — |
Return on assets | -3.76% | — |
Return on capital | -4.27% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.15M | -967.11% |
Cash from operations | 8.70M | 334.27% |
Cash from investing | -203.00K | -3,960.00% |
Cash from financing | -18.00K | -100.03% |
Net change in cash | 8.48M | -83.48% |
Free cash flow | 14.18M | 325.02% |
About
Harrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, TN.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its Chief Innovation Officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
Founded
2012
Headquarters
Website
Employees
315